A 12-week clevudine therapy showed durable antiviral activity and normalization of alanine transminase levels for 6 months after discontinuation of treatment in patients with chronic hepatitis B.

被引：0
|
作者：
Lee, HS
Chung, YH
Lee, KS
Byun, KS
Paik, SW
Han, JY
Yoo, K
Hwang, SG
Yoo, BC
Lee, JH
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Asan Med Ctr, Seoul, South Korea
[3] Yongdong Severance Hosp, Seoul, South Korea
[4] Korea Univ, Med Ctr, Guro Hosp, Seoul 136701, South Korea
[5] Samsung Med Ctr, Seoul, South Korea
[6] Catholic Univ Korea, St Marys Hosp, Seoul, South Korea
[7] Ewha Womans Univ, Mokdong Hosp, Seoul, South Korea
[8] Bukwang Pharm Co Ltd, Seoul, South Korea
[9] Hallym Univ Hosp, Seoul, South Korea
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：652A / 652A
页数：1
相关论文
共 13 条
  • [1] A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B
    Lee, HS
    Chung, YH
    Lee, K
    Byun, IS
    Paik, SW
    Han, JY
    Yoo, K
    Yoo, HW
    Lee, JH
    Yoo, BC
    HEPATOLOGY, 2006, 43 (05) : 982 - 988
  • [2] A 24-week Clevudine therapy showed a unique property of delayed time to viral rebound after treatment discontinuation in HBeAg(-) chronic hepatitis B
    Lee, H. -S.
    Yoo, H. -W.
    Yoo, B. -C.
    LIVER INTERNATIONAL, 2006, 26 : 13 - 14
  • [3] Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B
    Yoo, Byung Chul
    Kim, Ju Hyun
    Chung, Young-Hwa
    Lee, Kwan Sik
    Paik, Seung Woon
    Ryu, Soo Hyung
    Han, Byung Hoon
    Han, Joon-Yeol
    Byun, Kwan Soo
    Cho, Mong
    Lee, Heon-Ju
    Kim, Tae-Hun
    Cho, Se-Hyun
    Park, Joong-Won
    Um, Soon-Ho
    Hwang, Seong Gyu
    Kim, Young Soo
    Lee, Youn-Jae
    Chon, Chae Yoon
    Kim, Byung-lk
    Lee, Young-Suk
    Yang, Jin-Mo
    Kim, Haak Cheoul
    Hwang, Jae Seok
    Choi, Sung-Kyu
    Kweon, Young-Oh
    Jeong, Sook-Hyang
    Lee, Myung-Seok
    Choi, Jong-Young
    Kim, Dae-Ghon
    Kim, Yun Soo
    Lee, Heon Young
    Yoo, Kwon
    Yoo, Hee-Won
    Lee, Hyo-Suk
    HEPATOLOGY, 2007, 45 (05) : 1172 - 1178
  • [4] Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12-week clevudine therapy.
    Lee, KS
    Severance, YD
    Byun, KS
    Chung, YH
    Paik, SW
    Han, JY
    Yoo, K
    Hwang, SG
    Yoo, BC
    Lee, HS
    HEPATOLOGY, 2004, 40 (04) : 657A - 657A
  • [5] Comparisons the durability of 6 months and 12 months prolonged treatment duration after cessation chemotherapy in chronic hepatitis B patients with prophylaxis antiviral therapy: A open level randomized clinical trial
    Hu, T. -H.
    Tseng, P. -L.
    Tsai, M. C.
    Chang, K. -C.
    Yen, Y. -H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S111 - S111
  • [6] Correlations Between METAVIR Staging, the Viral Load and Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C, Before and after 12 Weeks of Antiviral Treatment
    Ciorba, Nicoleta Craciun
    Ciorba, Ilie Marius
    Puiac, Ion Claudiu
    Bancu, Ligia Ariana
    REVISTA DE CHIMIE, 2019, 70 (07): : 2420 - 2424
  • [7] Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
    Kim, Jeong Han
    Moon, Hee Won
    Ko, Soon Young
    Choe, Won Hyeok
    Kwon, So Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (03) : 274 - 282
  • [8] Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: Comparison between 6 and 12 months of therapy
    LopezAlcorocho, JM
    Bartolome, J
    Cotonat, T
    Carreno, V
    JOURNAL OF VIRAL HEPATITIS, 1997, 4 : 27 - 32
  • [9] Triple combination therapy in patients with chronic hepatitis B and non-response to interferon treatment - Interim analysis at 6 months after start of therapy
    Moser, A
    Lackner, H
    Triebl-Roth, K
    Dombusch, HJ
    Schwinger, W
    Sovinz, P
    Deutsch, J
    Kessler, HH
    Urban, C
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (02): : 153 - 153
  • [10] A 24-week clevudine monotherapy produced profound on-treatment viral suppression as well as sustained viral suppression and normalization of aminotransferase levels for 24 weeks off-treatment in HBeAg(+) chronic hepatitis B patients.
    Yoo, BC
    Kim, JH
    Lee, KS
    Kim, TH
    Paik, SW
    Ryu, SH
    Han, JY
    Cho, M
    Hwang, SG
    Kim, BI
    Lee, YS
    Kim, HC
    Hwang, JS
    Choi, SK
    Kim, YS
    Kweon, YO
    Choi, JY
    Lee, HY
    Yoo, HW
    Otto, MJ
    Furman, PA
    Lee, HS
    HEPATOLOGY, 2005, 42 (04) : 270A - 271A
12